1. Home
  2. RNXT vs GMM Comparison

RNXT vs GMM Comparison

Compare RNXT & GMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • GMM
  • Stock Information
  • Founded
  • RNXT 2012
  • GMM 2017
  • Country
  • RNXT United States
  • GMM China
  • Employees
  • RNXT N/A
  • GMM N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • GMM
  • Sector
  • RNXT Health Care
  • GMM
  • Exchange
  • RNXT Nasdaq
  • GMM Nasdaq
  • Market Cap
  • RNXT 24.0M
  • GMM 26.4M
  • IPO Year
  • RNXT 2021
  • GMM 2023
  • Fundamental
  • Price
  • RNXT $1.22
  • GMM $0.99
  • Analyst Decision
  • RNXT Strong Buy
  • GMM
  • Analyst Count
  • RNXT 3
  • GMM 0
  • Target Price
  • RNXT $6.13
  • GMM N/A
  • AVG Volume (30 Days)
  • RNXT 26.8K
  • GMM 467.5K
  • Earning Date
  • RNXT 11-12-2024
  • GMM 07-23-2024
  • Dividend Yield
  • RNXT N/A
  • GMM N/A
  • EPS Growth
  • RNXT N/A
  • GMM N/A
  • EPS
  • RNXT N/A
  • GMM 0.60
  • Revenue
  • RNXT N/A
  • GMM $33,985,284.00
  • Revenue This Year
  • RNXT N/A
  • GMM N/A
  • Revenue Next Year
  • RNXT N/A
  • GMM N/A
  • P/E Ratio
  • RNXT N/A
  • GMM $1.46
  • Revenue Growth
  • RNXT N/A
  • GMM 59.78
  • 52 Week Low
  • RNXT $0.53
  • GMM $0.65
  • 52 Week High
  • RNXT $2.35
  • GMM $15.47
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 62.13
  • GMM 61.84
  • Support Level
  • RNXT $0.98
  • GMM $0.79
  • Resistance Level
  • RNXT $1.25
  • GMM $0.94
  • Average True Range (ATR)
  • RNXT 0.10
  • GMM 0.07
  • MACD
  • RNXT 0.01
  • GMM 0.01
  • Stochastic Oscillator
  • RNXT 77.15
  • GMM 95.24

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About GMM Global Mofy Metaverse Limited

Global Mofy Metaverse Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.

Share on Social Networks: